Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-77c89778f8-m8s7h Total loading time: 0 Render date: 2024-07-20T07:46:00.371Z Has data issue: false hasContentIssue false

40 - Intractable Epilepsy

Implications with Regard to LAMICs

from Section 8 - Epilepsy Issues with Global Health Impact

Published online by Cambridge University Press:  13 April 2017

By
Alla B. Guekht
Edited by
Ennapadam S. Krishnamoorthy ,
Simon D. Shorvon  and
Steven C. Schachter
Ennapadam S. Krishnamoorthy
Affiliation:
Institute of Neurological Sciences, Chennai
Simon D. Shorvon
Affiliation:
University College London
Steven C. Schachter
Affiliation:
Harvard Medical School, Massachusetts
Get access

Summary

A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Chapter
Information
Epilepsy
A Global Approach
 , pp. 181 - 184
Publisher: Cambridge University Press
Print publication year: 2017

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Carpio, A, Hauser, W A. Epilepsy in the developing world. Curr Neurol Neurosci Rep. 2009; 9(4):319–26.CrossRefGoogle ScholarPubMed
Banerjee, P N, Filippi, D, Hauser, W A. The descriptive epidemiology of epilepsy – a review. Epilepsy Res. 2009;85(1):31–45.CrossRefGoogle ScholarPubMed
Aziz, H, Güvener, A, Akhtar, S W, Hasan, K Z. Comparative epidemiology of epilepsy in Pakistan and Turkey: population‐based studies using identical protocols. Epilepsia. 1997;38(6):716–22.Google ScholarPubMed
Rwiza, H T, Kilonzo, G P, Haule, J, et al. Prevalence and incidence of epilepsy in Ulanga, a rural Tanzanian district: a community‐based study. Epilepsia. 1992;33(6):1051–56.CrossRefGoogle ScholarPubMed
Birbeck, G L, Kalichi, E. Epilepsy prevalence in rural Zambia: a door‐to‐door survey. Trop Med Int Health. 2004;9(1):92–95.CrossRefGoogle ScholarPubMed
Nicoletti, A, Reggio, A, Bartoloni, A, et al. Prevalence of epilepsy in rural Bolivia. A door-to-door survey. Neurology. 1999;53(9):2064.CrossRefGoogle ScholarPubMed
Medina, M, Rosas, E, Rubio, F, et al. Neurocysticercosis as the main cause of late-onset epilepsy in Mexico. Arch Intern Med. 1990;150:325–27.CrossRefGoogle ScholarPubMed
Garcia-Noval, J, Allan, J C, Fletes, C. Epidemiology of Taenia solium taeniasis and cysticercosis in two rural Guatemalan communities. Am J Trop Med Hyg. 1996;55(3):282–89.CrossRefGoogle ScholarPubMed
Medina, M T, Durón, R M, Martínez, L, et al. Prevalence, incidence, and etiology of epilepsies in rural Honduras: the Salama Study. Epilepsia. 2005;46(1):124–31.CrossRefGoogle ScholarPubMed
Ngugi, A K, Bottomley, C, Kleinschmidt, I, et al. Prevalence of active convulsive epilepsy in sub-Saharan Africa and associated risk factors: cross-sectional and case-control studies. Lancet Neurol. 2013;12(3):253–63.Google Scholar
Pal, D K, Carpio, A, Sander, J W. Neurocysticercosis and epilepsy in developing countries. J Neurol Neurosurg Psychiatry. 2000;68(2):137–43.CrossRefGoogle ScholarPubMed
Thapa, A, Chandra, S P, Sinha, S, et al. Post-traumatic seizures – a prospective study from a tertiary level trauma center in a developing country. Seizure. 2010;19(4):211–16.CrossRefGoogle ScholarPubMed
Luciano, A L, Shorvon, S D. Results of treatment changes in patients with apparently drug-resistant chronic epilepsy. Ann Neurol. 2007;62(4):375–81.Google Scholar
Kwan, P, Schachter, S C, Brodie, M J. Drug-resistant epilepsy. New Engl J Med. 2011;365(10).CrossRefGoogle ScholarPubMed
Callaghan, B, Schlesinger, M, Rodemer, W, et al. Remission and relapse in a drug-resistant epilepsy population followed prospectively. Epilepsia. 2011;52:619–26.CrossRefGoogle Scholar
Kariuki, S M, Matuja, W, Akpalu, A, et al. Clinical features, proximate causes, and consequences of active convulsive epilepsy in Africa. Epilepsia. 2014;55(1):76–85.CrossRefGoogle ScholarPubMed
Birbeck, G, Chomba, E, Atadzhanov, M, et al. The social and economic impact of epilepsy in Zambia: a cross-sectional study. Lancet Neurol. 2007;6(1):39–44.CrossRefGoogle ScholarPubMed
Munyoki, G, Edwards, T, White, S, et al. Clinical and neurophysiologic features of active convulsive epilepsy in rural Kenya: a population‐based study. Epilepsia. 2010;51(12):2370–76.CrossRefGoogle ScholarPubMed
Mbodj, I, Ndiaye, M, Sene, F, et al. Treatment of status epilepticus in a developing country. Neurophysiol Clin. 2000;30(3):165–69.Google Scholar
Forsgren, L, Hauser, WA, Olafsson, E, et al. Mortality of epilepsy in developed countries: a review. Epilepsia. 2005;46(Suppl 11):18–27.CrossRefGoogle ScholarPubMed
Callaghan, B, Choi, H, Schlesinger, M. Increased mortality persists in an adult drug-resistant epilepsy prevalence cohort. J Neurol Neurosurg Psychiatry. 2014;85:1084–90.CrossRefGoogle Scholar
Diop, AG, Hesdorffer, DC, Logroscino, G, Hauser, W A. Epilepsy and mortality in Africa: a review of the literature. Epilepsia. 2005;46(Suppl 11):33–35.CrossRefGoogle Scholar
Kamgno, J, Pion, S D, Boussinesq, M. Demographic impact of epilepsy in Africa: results of a 10-year cohort study in a rural area of Cameroon. Epilepsia. 2003;44(7):956–63.CrossRefGoogle Scholar
Thomas, S V, Reghunath, B, Sankara Sarma, P. Mortality among epilepsy patients attending a tertiary referral center in a developing country. Seizure. 2001;10(5):370–73.Google Scholar
Berg, A T. Identification of pharmacoresistant epilepsy. Neurol Clin. 2009;27(4):1003–13.CrossRefGoogle ScholarPubMed
Kwan, P, Arzimanoglou, A, Brodie, M J, et al. Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia. 2010;51(6):1069–77.CrossRefGoogle Scholar
Guinhouya, K M, Aboki, A, Kombaté, D, et al. [The epilepsy treatment gap in six primary care centres in Togo (2007–2009)]. Sante. 2010;20(2):93–7.Google ScholarPubMed
Lomidze, G, Kasradze, S, Kvernadze, D, et al. The prevalence and treatment gap of epilepsy in Tbilisi, Georgia. Epilepsy Res. 2012;98(2–3):123–29.Google Scholar
Meyer, AC, Dua, T, Ma, J, Saxena, S, Birbeck, G. Global disparities in the epilepsy treatment gap: a systematic review. Bull World Health Org. 2010;88(4):260–66.Google Scholar
Neligan, A, Bell, G S, Elsayed, M, Sander, J W, Shorvon, S D. Treatment changes in a cohort of people with apparently drug-resistant epilepsy: an extended follow-up. J Neurol Neurosurg Psychiatry. 2012;83(8):810–13.Google Scholar
Brodie, M J, Barry, S J, Bamagous, G A, Kwan, P. Effect of dosage failed of first antiepileptic drug on subsequent outcome. Epilepsia. 2013;54(1):194–98.CrossRefGoogle ScholarPubMed
Hao, X, Goldberg, D, Kelly, K, et al. Uncontrolled epilepsy is not necessarily the same as drug-resistant epilepsy: differences between populations with newly diagnosed epilepsy and chronic epilepsy. Epilepsy Behav. 2013;29(1):4–6.CrossRefGoogle Scholar
Kwan, P, Brodie, M J. Early identification of refractory epilepsy. New Engl J Med. 2000; 342(5):314–19.Google Scholar
Radhakrishnan, K, So, E L, Silbert, P L, et al. Prognostic implications of seizure recurrence in the first year after anterior temporal lobectomy. Epilepsia. 2003;44(1):77–80.CrossRefGoogle ScholarPubMed
Boling, W, Palade, A, Wabulya, A, et al. Surgery for pharmacoresistant epilepsy in the developing world: a pilot study. Epilepsia. 2009;50(5):1256–61.CrossRefGoogle ScholarPubMed
Wu, X T, Li, L, Yan, B, et al. How to effectively constrain the cost of presurgical evaluation for resective surgery in low-income population: clinically oriented opinions. Seizure. 2011;20(5):425–27.CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×